Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Philipp Jurmeister
Affiliation
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
ORCID
Career Start Year
2015
Papers
37
H Index
14
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37871132
Toward Explainable Artificial Intelligence for Precision Pathology.
Annu Rev Pathol
2024
36376255
Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements.
Histopathology
2023
34325051
Arthroprosthetic titanium and vanadium exposure - Confounder or cause of multiorgan morbidity.
Joint Bone Spine
2022
35403871
[Artificial intelligence: a solution for the lack of pathologists?]
Pathologe
2022
35780228
New entity of microsecretory adenocarcinoma of salivary glands: first case with recurrence and metastases - proof of malignancy.
Virchows Arch
2022
35749951
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas.
Lung Cancer
2022
35681790
Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers.
Cancers (Basel)
2022
36443295
DNA methylation-based classification of sinonasal tumors.
Nat Commun
2022
36397403
Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study.
Medicine (Baltimore)
2022
33631297
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling.
Semin Cancer Biol
2022
34878655
Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation.
J Pathol
2022
35262195
The single-cell transcriptional landscape of lung carcinoid tumors.
Int J Cancer
2022
34737214
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth.
Cancer Res
2022
34844086
Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis.
Pathol Res Pract
2022
34564861
Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
J Pathol
2022
34281986
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma.
J Immunother Cancer
2021
34602069
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status.
Clin Epigenetics
2021
34265800
IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
Am J Surg Pathol
2021
34173019
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing.
Virchows Arch
2021
32143905
Dissecting the spatial heterogeneity of different immune cell subsets in non-small cell lung cancer.
Pathol Res Pract
2020
33344431
Primary Extracellular Matrix Enables Long-Term Cultivation of Human Tumor Oral Mucosa Models.
Front Bioeng Biotechnol
2020
32945916
[Quality assurance in diagnostic in situ hybridization-experience of QuIP].
Pathologe
2020
32601356
Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis.
Lab Invest
2020
32795620
A multilayered epithelial mucosa model of head neck squamous cell carcinoma for analysis of tumor-microenvironment interactions and drug development.
Biomaterials
2020
30379727
Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological Findings.
Invest Radiol
2019
31634654
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
Lung Cancer
2019
31803175
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.
Front Immunol
2019
31437373
Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
J Dtsch Dermatol Ges
2019
31511427
Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.
Sci Transl Med
2019
30887194
Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings.
Eur Radiol
2019
30723296
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Mod Pathol
2019
30428389
Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
Hum Pathol
2019
29568525
Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum.
SAGE Open Med Case Rep
2018
29951738
[Early diagnosis and localization of cancer by liquid biopsy].
Pathologe
2018
30466405
RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
BMC Cancer
2018
25534130
Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.
Lung Cancer
2015
26547803
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making.
Lung Cancer
2015
1 - 37 of 37
Column Actions
Search
Recommended Authors
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year
2013
Number of shared co-authors
0
Nazim Benzerdjeb
Institut de Pathologie Multisite
Career Start Year
2013
Number of shared co-authors
0
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
2012
Number of shared co-authors
1
David A Moore
University College London Cancer Institute
Career Start Year
2012
Number of shared co-authors
2
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year
2012
Number of shared co-authors
1
Carlos E de Andrea
University of Navarra
Career Start Year
2010
Number of shared co-authors
0
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year
2008
Number of shared co-authors
0
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year
2008
Number of shared co-authors
0
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year
2008
Number of shared co-authors
1
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2007
Number of shared co-authors
10
Iacopo Petrini
University of Pisa
Career Start Year
2006
Number of shared co-authors
0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
12
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year
2005
Number of shared co-authors
0
Daisuke Komura
Graduate School of Medicine, The University of Tokyo
Career Start Year
2005
Number of shared co-authors
0
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year
2004
Number of shared co-authors
1
Simion I Chiosea
University of Pittsburgh
Career Start Year
2003
Number of shared co-authors
2
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year
2002
Number of shared co-authors
0
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year
2000
Number of shared co-authors
3
Steve E Kalloger
University of British Columbia
Career Start Year
2000
Number of shared co-authors
1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year
1999
Number of shared co-authors
0
Patrick Micke
Uppsala University
Career Start Year
1997
Number of shared co-authors
0
Prudence A Russell
St Vincent's Hospital
Career Start Year
1997
Number of shared co-authors
1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
0
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
6
David L Rimm
Yale University School of Medicine
Career Start Year
1980
Number of shared co-authors
7
Hans Brunnstr??m
Lund University
Career Start Year
1977
Number of shared co-authors
1
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
1
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year
1972
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers
16
David Capper
Charite University Medicine Berlin
Co-authored papers
10
Michael Bockmayr
Institute of Pathology, Charite Universitatsmedizin Berlin
Co-authored papers
7
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
4
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
4
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers
4
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
3
Leonille Schweizer
Co-authored papers
3
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers
3
Andreas von Deimling
Co-authored papers
2
Maximilian Alber
Institute of Pathology, Charite Universitatsmedizin Berlin
Co-authored papers
2
Klaus-Robert M??ller
Google Research
Co-authored papers
2
Pascal D Johann
Co-authored papers
2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers
1
Martin Sill
Co-authored papers
1
Jörn Walter
Co-authored papers
1
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers
1
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers
1
Philipp Mertins
Co-authored papers
1
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
1
Danny Jonigk
Institut fur Pathologie
Co-authored papers
1
Frank Tacke
Charite-Universitatsmedizin Berlin
Co-authored papers
1
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
1
David G Pfister
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers
1
Stephan Frank
Universitatsspital Basel
Co-authored papers
1
Johannes Eschrich
Clinic for Hepatology and Gastroenterology, Charite University Medical Center
Co-authored papers
1
Daniel Baumhoer
Co-authored papers
1
Alex H Wagner
Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis
Co-authored papers
1
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
1
1 - 30